

Accepting Applications: Support for Partnering and Seeking Third-Party Investment
The NHLBI is offering current and recent NHLBI grantees the opportunity to participate in investing and partnering events. For each event in the table below, your company might be eligible to apply for up to two paid registrations (for the CEO or business development lead). Partnering and/or exhibit space may also be available at the event.
Event | Focus | Technology Type | Date | Location |
Angel Capital Association – The Summit of Angel Investing | Early-stage investment | Biopharma, medical devices, research tools, digital health | May 16–18, 2023 | In-Person: Las Vegas, Nevada |
BIO International Convention | Early-stage investment | Biopharma, medical devices, research tools | June 5–8, 2023 | In-Person: Boston, MA |
Landmark Forum – Healthy Innovations | Seed and early-stage investment | Medical devices, diagnostics, clinical stage biopharma | Dates: TBD |
TBD |
Young Startup | Early-stage investment through series C | Biopharma, medical devices, diagnostics, digital health | March 2023
|
In-Person: Silicon Valley
|
Companies eligible for the program should have received an invitation via email with an NHLBI-specific link. To be considered for these events, please complete the online application form linked in that email or here by January 20th, 2023. You will be notified within 3–4 months if you have been matched to one of the current events or if you may be a better fit for a future event. Please note that not all companies who apply will be matched to events.
More information and FAQs may be found at NOT-OD-23-019 and on the NIH SEED Web site. For more information about the support and types of events, please contact Julia Berzhanskaya at Julia.berzhanskaya@nih.gov.